Gene therapy may be 'one-shot stop' for rare bone disease
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...
thecardiologyadvisor.com22h
AHA Scientific Statement About CV Risk With Assisted Reproductive Technology
A scientific statement has been published by the AHA regarding obstetric and cardiovascular risk in patients receiving assisted reproductive technology.
News Medical on MSN16h
Kennesaw State researcher receives American Heart Association grant to study heart valve disease
Kennesaw State University mechanical engineering professor Philippe Sucosky has earned a prestigious American Heart ...